Blocking a key gene regulator may restore immune response in cancer therapy

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body’s immune system to target tumors. Despite their initial clinical success, many patients eventually experience diminished therapeutic responses as tumors…

Continue Reading

News Source: medicalxpress.com